Capmatinib hydrochloride CAS 1865733-40-9 high quality
ISO
1865733-40-9
Pharmaceutical Grade
99.54%
Million
25kg/Cardboard Drum
Yes
2100-12-31
Avanafil,Tirzepatide,Semaglutide,Pregabalin,Nootropics,MT2
-
Product Description
-
Seller Information
-
DescriptionECHEMI Editorial ReferenceCapmatinib Hydrochloride is the hydrochloride salt form of capmatinib, an orally bioavailable inhibitor of the proto-oncogene c-Met (also known as hepatocyte growth factor receptor (HGFR)) with potential antineoplastic activity. Capmatinib selectively binds to c-Met, thereby inhibiting c-Met phosphorylation and disrupting c-Met signal transduction pathways. This may induce cell death in tumor cells overexpressing c-Met protein or expressing constitutively activated c-Met protein. c-Met, a receptor tyrosine kinase overexpressed or mutated in many tumor cell types, plays key roles in tumor cell proliferation, survival, invasion, metastasis, and tumor angiogenesis.
Capmatinib dihydrochloride hydrate is a orally active,reversible MET tyrosine kinase inhibitor that received approval for advanced non-small cell lung cancer(NSCLC) harboring MET exon 14 skipping mutationa. Capmatinib dihydrochloride hydrate can inhibit phosphorylation of c-MET as well as c-MET pathway downstream effectors such as ERK1/2, AKT, FAK, GAB1, and STAT3/5. Capmatinib dihydrochloride hydrate potently inhibits c-MET-dependent tumor cell proliferation and migration and effectively induces apoptosis. Antitumor activity. Capmatinib dihydrochloride hydrate is largely metabolized by CYP3A4 and aldehyde oxidase[1-3].CertificatesBasic Info-
Product Name:
Capmatinib hydrochloride
Other Name:Capmatinib hydrochloride;Capmatinib HCl hydrate (INCB-28060;Capmatinib 2HCl.H2O;INC-280 2HCl.H2O;INCB28060 2HCl.H2O;NVP-INC280 2HCl.H2O;Capmatinib Hydrochloride Hydrate (INCB28060);S114,SNU-5,ATP competitive,Balb/c nu/nu mice,U-87MG,INCB-28060 dihydrochloride,orally active,Capmatinib dihydrochloride,Capmatinib 2HCl.H-2O,Capmatinib 2HCl.H2O,INC280 dihydrochloride,Apoptosis,inhibit,Inhibitor,c-Met/HGFR,H441
CAS No.:1865733-40-9
Molecular Formula:C23H20ClFN6O2
InChIKeys:XCHIKTXPDQTRMI-UHFFFAOYSA-N
Molecular Weight:466.9
Exact Mass:502.1087075
UNII:C2A374O70X
NCI Thesaurus Code:C138995
Color/Form:White to light yellow
Categories:
Characteristics-
Toxicity:
Effects During Pregnancy and Lactation No information is available on the clinical use of capmatinib during breastfeeding. Because capmatinib is 96% bound to plasma proteins, the amount in milk is likely to be low. The manufacturer recommends that breastfeeding be discontinued during capmatinib therapy and for 1 week after the last dose.
-
-
Seller Information
-
Business Type:
Manufactory
-
Main Products:
Avanafil,Tirzepatide,Semaglutide,Pregabalin,Nootropics,MT2
-
Location:
Room 1-2208, Lianhecaifu Square, No2177, Tianchen Road, Gaoxin District, Jinan City, Shandong Province, China
-
Payment Terms:
L/C,100% TT in advance
-
Average lead Time:
3 days
-
Total Annual Revenue:
$1 million-$2.5 million
-
Total Employees:
11-50
-
Year of Establishment:
2012
Company Certificates-
business license
-
-
Country Product Purchase Quantity Date Posted Post an enquiry for this product
More from this Seller
-
-
-
Estradiol valerate cas 979-32-8
Pharmaceutical Grade / 99.66%
$1.9/G FOB
-
-
-
-
Mt2 Slu pp 32 Slu-pp-332 Melanotan
Pharmaceutical Grade / 99.89%
$1.9/MT EXW
-
-
-
-
High- Quality Erdafitinib 99% powder 1346242-81-6 Erdafitinib
Pharmaceutical Grade / 99.00%
$1/G FOB
-
-
-
-
Diphenhydramine HCL CAS 147-24-0 99% High Purity White Powder Hot Sale Pharmaceutical Best Service
Pharmaceutical Grade / 99.45%
$2.54/MT FOB
-
-
-
-
Eplerenone cas no 107724-20-9
Pharmaceutical Grade / 99.75%
$2.1/G FOB
-
-
-
-
Trizepatide tirzepatide
Pharmaceutical Grade / 99.9%
$0.8/MT FOB
-







